Načítá se...
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
High human equilibrative nucleoside transporter 1 (hENT1)-expression has shown a survival benefit in pancreatic cancer patients treated with gemcitabine in several studies. The aim of this systematic review was to summarize the results and try to assess the predictive value of hENT1 for determining...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4093699/ https://ncbi.nlm.nih.gov/pubmed/25024604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i26.8482 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|